Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome — Stella

Home/DiGeorge Syndrome/

View on ClinicalTrials.gov

Recruiting

Back to DiGeorge Syndrome trials

Trial locations(1 site)

United States

Albert Einstein College of Medicine, New York, New York

Key details

Sponsor

Albert Einstein College of Medicine

Collaborators

National Heart, Lung, and Blood Institute (NHLBI), Children's Hospital of Philadelphia

Enrollment target

~1,000 participants

Started

July 2016

Primary completion

June 2029

Last updated July 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.